RA

Rishikappur Alias Manoj

Active Director Director DIN 10167463
DIN 10167463 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rishikappur Alias Manoj

Data last updated:

Rishikappur Alias Manoj is a Director at Medever Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10167463
Primary Designation Director
Industry Pharma
First Appointment 17 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 May 20232023Active

Board colleagues of Rishikappur Alias Manoj

NameDINCompanyDesignation
Ramasamy Rajendiran10167462Medever Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medever Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Rishikappur Alias Manoj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rishikappur Alias Manoj

Rishikappur Alias Manoj currently holds 1 directorship: Medever Pharmaceutical Private Limited (Director, since 17 May 2023).

Rishikappur Alias Manoj was first appointed on 17 May 2023 as Director at Medever Pharmaceutical Private Limited.

The current boards of Rishikappur Alias Manoj's companies include Ramasamy Rajendiran (Medever Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available